Trademark Overview
On Wednesday, March 19, 2025, a trademark application was filed for OLIGOCREATOR with the United States Patent and Trademark Office. The USPTO has given the OLIGOCREATOR trademark a serial number of 79426139. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, April 21, 2026. This trademark is owned by Secarna Pharmaceuticals GmbH & Co. KG. The OLIGOCREATOR trademark is filed in the Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:
Scientific research services in the fields of biochemistry, nucleic acids, and bioinformatics, excluding the field of cell culture product, in particular molecular biology techniques, especially antisense techniques; design of pharmaceutical active ingredients by the use of bioinformatics techniques; development of pharmaceutical products by the use of bioinformatics techniques being testing and diagnostic procedures; bioinformatic services for scientific research purposes in the pharmaceutical and biotechnological industry, namely, computational design and optimization of oligonucleotide sequences, sequence analysis of nucleic acids, target identification and validation using bioinformatic methods, in silico screening and prediction of efficacy, safety and off-target effects of nucleic acid therapeutics, analysis of gene expression and multiomics data, integration and analysis of biological data sets, selection of candidate oligonucleotides based on computational and experimental data...
Consultancy services to third parties in the field of biochemistry and nucleic acids and bioinformatics, namely, using antisense technology for the development of pharmaceutical products; consultancy services to third parties in the field of the evaluation of safety and efficacy of pharmaceuticals
Licensing of industrial property rights arising from scientific research services in the fields of biochemistry, nucleic acids, and bioinformatics, excluding the field of cell culture products, in particular molecular biology techniques, especially antisense techniques; licensing of industrial property rights arising from the design of pharmaceutical active ingredients using molecular biology techniques, especially antisense techniques; licensing of industrial property rights arising from the development of pharmaceutical products using molecular biology techniques being testing and diagnostic procedures; licensing of industrial property rights arising from bioinformatic services for the pharmaceutical and biotechnological industry; licensing of industrial property rights arising from the services for evaluating the efficacy and safety of pharmaceutical products
